We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Physician Office Testing Found Responsive to Developing World Needs

By LabMedica International staff writers
Posted on 08 Dec 2014
Print article
The points of strongest demand in the global physician office laboratory (POL) sector have converged around testing related to lifestyle diseases, according to a new report from Kalorama Information (New York City, NY, USA). Also, use of the most-performed POL tests is quickly growing in the developing world.

Of the 10 fastest growing tests in the POL market over the next 5 years, 6 are related to diseases such as diabetes, heart disease, thrombosis, and colon cancer. The growth of such POL test markets (projected each at over 5% annually) is a result not only of increasing utilization in US preventative care, but also of adoption in near-patient testing in the developing world. POL testing, completed during or in conjunction to a primary care visit, has been adopted worldwide to improve routine care using diagnostic technologies able to be leveraged outside of more centralized laboratory settings.

According to Kalorama’s report “Physician Office Laboratory Markets, 3rd Edition,” microalbumin, c-reactive protein (CRP), glycosylated hemoglobin (HbA1c), D-dimer, cardiac markers, and fecal occult blood (FOB) tests will see above-average POL market growth to reach nearly 16% of the total POL market in 2019. All six tests and test-families can be performed with rapid results. FOB and HbA1c tests are 2 of the 12 most-performed POL tests in the US market; 3 of the tests (FOB, HbA1c, cardiac markers) can be performed without CLIA lab certification.

The surprising aspect of market success, however, is their fast-growing application in developing markets. “POL or physician office testing isn't typically associated with the developing world: outside of the United States, Europe, and Japan, there's only 5% of the global market remaining,” explained Emil Salazar, report analyst for Kalorama Information, “But as growth has cooled in more established POL markets in the past few years, we are seeing rising placements of near-patient and POC test devices at clinics in India and China.”

A confluence of factors in India has particularly assisted development of the POL market. Economic development and rising incomes have unfortunately increased the prevalence of diabetes and cardiovascular disease. Amid uneven and at times problematic healthcare modernization in India, patients there have turned to private clinics and primary healthcare centers modeled after Western practices. In such institutions, POL testing is increasingly a fixture valuable in reassuring patients through timely, in-house performed test results. A fleet of tests are expected to see deployment in rest-of-world (ROW) POL markets, including CRP, glucose, HbA1c, basic lipid profiles, and cardiac markers CK and BNP.

The expansive market selection of POL tests is analyzed through a series of market segments in Kalorama’s report, as are the varying prospects of national and regional POL markets.

Related Links:

Kalorama Information
Physician Office Laboratory (POL) Markets, 3rd Edition


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.